Home
中文
About Us
> CEO Statement
> At a Glance
> Mission and Values
> Global Recognition
> History and Milestones
> Management Team
> Brochure
Therapeutic Focus
> Oncology
> Autoimmune Diseases
Products
> Pipeline Overview
> HMPL-004
> HMPL-011
> HMPL-012
> HMPL-013
> HMPL-813
Research & Development
> Drug Discovery Research
> Drug Development
> Facility and Capacity
Collaborations
> Overview
> Existing Partnerships
Media
> Key Facts
> Press Releases
> Featured Articles
Careers
Contacts
Existing Partnerships
Our Corporate Partners
Johnson and Johnson
Eli Lilly and Company
Merck Serono
Procter & Gamble
Our Institute and Hospital Partners
Cambridge University
University of Maryland
Cedars-Sinai Medical Center
Mayo Clinic
University of California, Los Angeles
Shanghai Institute of Materia Medica
Shanghai Institute of Pharmaceutical Industry
National Shanghai Center for New Drug Safety Evaluation and Research
Institute for Nutritional Sciences
Shanghai University of TCM
Peking University School of Pharmaceutical Sciences
Shenyang Pharmaceutical University
Chinese PLA General Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing Cancer Hospital
Zhongshan Hospital Fudan University
Shanghai Chest Hospital
Changhai Hospital of Shanghai
Top
Back home
Print page
